{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T21:02:12Z","timestamp":1780002132543,"version":"3.53.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,28]]},"DOI":"10.7759\/cureus.109831","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:09:06Z","timestamp":1779998946000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Profile, Radiologic Features, and Clinical Course of Tumefactive Demyelinating Lesions in Two Tertiary Medical Centers in the Philippines: An 11-Year Retrospective Study"],"prefix":"10.7759","author":[{"given":"Bernard Kean M","family":"Capinpin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig F","family":"Damian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105408","article-title":"Clinical and radiological characteristics and outcomes of patients with recurrent or relapsing tumefactive demyelination","volume":"82","author":"Pervin I","year":"2024","unstructured":"Pervin I, Ramanathan S, Cappelen-Smith C, Vucic S, Reddel SW, Hardy TA. Clinical and radiological characteristics and outcomes of patients with recurrent or relapsing tumefactive demyelination. Mult Scler Relat Disord. 2024, 82:105408. 10.1016\/j.msard.2023.105408","journal-title":"Mult Scler Relat Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004386","article-title":"Clinical reasoning: a 50-year-old woman with SLE and a tumefactive lesion","volume":"89","author":"Choi JH","year":"2017","unstructured":"Choi JH, Wallach AI, Rosales D, Margiewicz SE, Belmont HM, Lucchinetti CF, Minen MT. Clinical reasoning: a 50-year-old woman with SLE and a tumefactive lesion. Neurology. 2017, 89:140-5. 10.1212\/WNL.0000000000004386","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000527","article-title":"Paraneoplastic recurrent tumefactive demyelination in a 62-year-old man with metastatic seminoma","volume":"6","author":"Thebault S","year":"2019","unstructured":"Thebault S, Hanes I, Woulfe J, Bourque PR. Paraneoplastic recurrent tumefactive demyelination in a 62-year-old man with metastatic seminoma. Neurol Neuroimmunol Neuroinflamm. 2019, 6:527. 10.1212\/NXI.0000000000000527","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000206820","article-title":"Tumefactive demyelination in MOG AB-associated disease, multiple sclerosis, and AQP-4-IgG-positive neuromyelitis optica spectrum disorder","volume":"100","author":"Cacciaguerra L","year":"2023","unstructured":"Cacciaguerra L, Morris P, Tobin WO, et al.. Tumefactive demyelination in MOG AB-associated disease, multiple sclerosis, and AQP-4-IgG-positive neuromyelitis optica spectrum disorder. Neurology. 2023, 100:1418-32. 10.1212\/WNL.0000000000206820","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52048-w","article-title":"Tumefactive demyelinating lesions: a retrospective cohort study in Thailand","volume":"14","author":"Ongphichetmetha T","year":"2024","unstructured":"Ongphichetmetha T, Aungsumart S, Siritho S, et al.. Tumefactive demyelinating lesions: a retrospective cohort study in Thailand. Sci Rep. 2024, 14:1426. 10.1038\/s41598-024-52048-w","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.106168","article-title":"Etiology and characteristics of pseudotumoral lesions and tumefactive demyelination in multiple sclerosis","volume":"92","author":"Tamas O","year":"2024","unstructured":"Tamas O, Kovacevic M, Veselinovic N, et al.. Etiology and characteristics of pseudotumoral lesions and tumefactive demyelination in multiple sclerosis. Mult Scler Relat Disord. 2024, 92:106168. 10.1016\/j.msard.2024.106168","journal-title":"Mult Scler Relat Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2055217319855755","article-title":"Tumefactive demyelination: clinical outcomes, lesion evolution and treatments","volume":"5","author":"Brod SA","year":"2019","unstructured":"Brod SA, Lindsey JW, Nelson F. Tumefactive demyelination: clinical outcomes, lesion evolution and treatments. Mult Scler J Exp Transl Clin. 2019, 5:2055217319855755. 10.1177\/2055217319855755","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51844","article-title":"Defining the natural history of tumefactive demyelination: a retrospective cohort of 257 patients","volume":"10","author":"Fereidan-Esfahani M","year":"2023","unstructured":"Fereidan-Esfahani M, Decker PA, Weigand SD, et al.. Defining the natural history of tumefactive demyelination: a retrospective cohort of 257 patients. Ann Clin Transl Neurol. 2023, 10:1544-55. 10.1002\/acn3.51844","journal-title":"Ann Clin Transl Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/20552173261416215","article-title":"Tumefactive demyelination in older adults: a scoping review of published cases","volume":"12","author":"De Pasquale C","year":"2026","unstructured":"De Pasquale C, Hardy TA. Tumefactive demyelination in older adults: a scoping review of published cases. Mult Scler J Exp Transl Clin. 2026, 12:20552173261416215. 10.1177\/20552173261416215","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8984-7","article-title":"Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients","volume":"265","author":"Balloy G","year":"2018","unstructured":"Balloy G, Pelletier J, Suchet L, et al.. Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients. J Neurol. 2018, 265:2251-9. 10.1007\/s00415-018-8984-7","journal-title":"J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15182","article-title":"Population-based incidence and clinico-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States","volume":"29","author":"Fereidan-Esfahani M","year":"2022","unstructured":"Fereidan-Esfahani M, Decker PA, Eckel Passow JE, Lucchinetti CF, Flanagan EP, Tobin WO. Population-based incidence and clinico-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States. Eur J Neurol. 2022, 29:782-9. 10.1111\/ene.15182","journal-title":"Eur J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.13970","article-title":"Performance of apparent diffusion coefficient values and conventional MRI features in differentiating tumefactive demyelinating lesions from primary brain neoplasms","volume":"205","author":"Mabray MC","year":"2015","unstructured":"Mabray MC, Cohen BA, Villanueva-Meyer JE, Valles FE, Barajas RF, Rubenstein JL, Cha S. Performance of apparent diffusion coefficient values and conventional MRI features in differentiating tumefactive demyelinating lesions from primary brain neoplasms. AJR Am J Roentgenol. 2015, 205:1075-85. 10.2214\/AJR.14.13970","journal-title":"AJR Am J Roentgenol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5775","article-title":"MRI findings in tumefactive demyelinating lesions: a systematic review and meta-analysi","volume":"39","author":"Suh CH","year":"2018","unstructured":"Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ. MRI findings in tumefactive demyelinating lesions: a systematic review and meta-analysi. AJNR Am J Neuroradiol. 2018, 39:1643-9. 10.3174\/ajnr.A5775","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/951690","article-title":"Open-ring enhancement in pseudotumoral multiple sclerosis: important radiological aspect","volume":"2014","author":"de Medeiros FC","year":"2014","unstructured":"de Medeiros FC, de Albuquerque LA, Pittella JE, de Souza RB, Gomes Neto AP, Christo PP. Open-ring enhancement in pseudotumoral multiple sclerosis: important radiological aspect. Case Rep Neurol Med. 2014, 2014:951690. 10.1155\/2014\/951690","journal-title":"Case Rep Neurol Med"},{"key":"ref15","article-title":"Proton MR spectroscopy of tumefactive demyelinating lesions","volume":"23","author":"Saindane AM","year":"2002","unstructured":"Saindane AM, Cha S, Law M, Xue X, Knopp EA, Zagzag D. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol. 2002, 23:1378-86.","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.08.025","article-title":"Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas","volume":"26","author":"Ikeguchi R","year":"2018","unstructured":"Ikeguchi R, Shimizu Y, Abe K, et al.. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas. Mult Scler Relat Disord. 2018, 26:77-84. 10.1016\/j.msard.2018.08.025","journal-title":"Mult Scler Relat Disord"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2015.327","article-title":"Perfusion imaging of tumefactive demyelinating lesions compared to high grade gliomas","volume":"43","author":"Parks NE","year":"2016","unstructured":"Parks NE, Bhan V, Shankar JJ. Perfusion imaging of tumefactive demyelinating lesions compared to high grade gliomas. Can J Neurol Sci. 2016, 43:316-8. 10.1017\/cjn.2015.327","journal-title":"Can J Neurol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1971400919826394","article-title":"Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques","volume":"32","author":"Barbosa BC","year":"2019","unstructured":"Barbosa BC, Marchiori E, Leal Leidersnaider C, Brandao L, Castillo M. Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques. Neuroradiol J. 2019, 32:103-7. 10.1177\/1971400919826394","journal-title":"Neuroradiol J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-3399614","article-title":"Tumefactive demyelination associated with bilateral optic neuritis in neuromyelitis optica spectrum disorders","volume":"10","author":"Verma R","year":"2019","unstructured":"Verma R, Kumar C. Tumefactive demyelination associated with bilateral optic neuritis in neuromyelitis optica spectrum disorders. J Neurosci Rural Pract. 2019, 10:693-6. 10.1055\/s-0039-3399614","journal-title":"J Neurosci Rural Pract"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.11.002","article-title":"The coexistence of recurrent cerebral tumefactive demyelinating lesions with longitudinally extensive transverse myelitis and demyelinating neuropathy","volume":"27","author":"Ciron J","year":"2019","unstructured":"Ciron J, Carra-Dalli\u00e8re C, Ayrignac X, Neau JP, Maubeuge N, Labauge P. The coexistence of recurrent cerebral tumefactive demyelinating lesions with longitudinally extensive transverse myelitis and demyelinating neuropathy. Mult Scler Relat Disord. 2019, 27:223-5. 10.1016\/j.msard.2018.11.002","journal-title":"Mult Scler Relat Disord"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2026.02.010","article-title":"Decisive role of brain biopsy in atypical tumefactive demyelinating lesions: a case report","volume":"21","author":"B\u00fclb\u00fcl NG","year":"2026","unstructured":"B\u00fclb\u00fcl NG, Jusupova A, Belen BG, et al.. Decisive role of brain biopsy in atypical tumefactive demyelinating lesions: a case report. Radiol Case Rep. 2026, 21:2360-7. 10.1016\/j.radcr.2026.02.010","journal-title":"Radiol Case Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-026-04947-w","article-title":"Biopsy-proven tumefactive demyelinating lesions: a systematic review and meta-analysis","author":"Alaskar MA","year":"2026","unstructured":"Alaskar MA, Alissa M, Alsaber N, Aljarallah S. Biopsy-proven tumefactive demyelinating lesions: a systematic review and meta-analysis. BMC Neurol. 2026, 10.1186\/s12883-026-04947-w","journal-title":"BMC Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.107788","article-title":"Tumefactive demyelinating lesions: a clinicopathological correlative study","volume":"55","author":"Neelima R","year":"2012","unstructured":"Neelima R, Krishnakumar K, Nair MD, Kesavadas C, Hingwala DR, Radhakrishnan VV, Nair SS. Tumefactive demyelinating lesions: a clinicopathological correlative study. Indian J Pathol Microbiol. 2012, 55:496-500. 10.4103\/0377-4929.107788","journal-title":"Indian J Pathol Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.868525","article-title":"Immunopathology of tumefactive demyelinating lesions-from idiopathic to drug-related cases","volume":"13","author":"Vakrakou AG","year":"2022","unstructured":"Vakrakou AG, Brinia ME, Svolaki I, Argyrakos T, Stefanis L, Kilidireas C. Immunopathology of tumefactive demyelinating lesions-from idiopathic to drug-related cases. Front Neurol. 2022, 13:868525. 10.3389\/fneur.2022.868525","journal-title":"Front Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09328-7","article-title":"Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions","volume":"266","author":"Ayrignac X","year":"2019","unstructured":"Ayrignac X, Rigau V, Lhermitte B, et al.. Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions. J Neurol. 2019, 266:1743-55. 10.1007\/s00415-019-09328-7","journal-title":"J Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211006503","article-title":"Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases","volume":"14","author":"Vakrakou AG","year":"2021","unstructured":"Vakrakou AG, Tzanetakos D, Evangelopoulos ME, et al.. Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases. Ther Adv Neurol Disord. 2021, 14:17562864211006503. 10.1177\/17562864211006503","journal-title":"Ther Adv Neurol Disord"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1052678","article-title":"Central nervous system tumefactive demyelinating lesions: risk factors of relapse and follow-up observations","volume":"13","author":"Li X","year":"2022","unstructured":"Li X, Miao X, Wang Y, et al.. Central nervous system tumefactive demyelinating lesions: risk factors of relapse and follow-up observations. Front Immunol. 2022, 13:1052678. 10.3389\/fimmu.2022.1052678","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102510","article-title":"The current status and challenges in multiple sclerosis management in the Philippines","volume":"46","author":"Ignacio KH","year":"2020","unstructured":"Ignacio KH, Espiritu AI, Jamora RD. The current status and challenges in multiple sclerosis management in the Philippines. Mult Scler Relat Disord. 2020, 46:102510. 10.1016\/j.msard.2020.102510","journal-title":"Mult Scler Relat Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/494085-clinical-profile-radiologic-features-and-clinical-course-of-tumefactive-demyelinating-lesions-in-two-tertiary-medical-centers-in-the-philippines-an-11-year-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:09:06Z","timestamp":1779998946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/494085-clinical-profile-radiologic-features-and-clinical-course-of-tumefactive-demyelinating-lesions-in-two-tertiary-medical-centers-in-the-philippines-an-11-year-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.109831","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,28]]}}}